Orient Europharma Co Ltd Cash Flow Reinvestment Rate
Orient Europharma Co Ltd cash flow reinvestment rate. Orient Europharma Co Ltd (4120) has a Cash Flow Reinvestment Rate of 44.08x as of June 2025, reinvesting NT$1.47 Billion (capex NT$89.03 Million plus investments NT$1.38 Billion) from operating cash flow of NT$33.25 Million. Explore Orient Europharma Co Ltd (4120) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Orient Europharma Co Ltd (2015–2023)
Cash flow reinvestment rate of Orient Europharma Co Ltd from 2015 to 2023. Historical reinvestment intensity for Orient Europharma Co Ltd across 8 annual periods. Explore 4120 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Orient Europharma Co Ltd Cash Flow Reinvestment Rate by Year (2015–2023)
Orient Europharma Co Ltd cash flow reinvestment rate by year from 2015 to 2023. Year-by-year capital reinvestment analysis for Orient Europharma Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Orient Europharma Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.44x | NT$351.83 Million | NT$64.67 Million | NT$100.70 Million | ▼ -75.1% |
| 2021 | 21.89x | NT$1.70 Billion | NT$77.65 Million | NT$1.56 Billion | ▲ +3647.9% |
| 2020 | 0.58x | NT$355.35 Million | NT$608.55 Million | NT$232.78 Million | ▲ +4.4% |
| 2019 | 0.56x | NT$127.14 Million | NT$227.37 Million | NT$124.98 Million | ▼ -36.0% |
| 2018 | 0.87x | NT$202.21 Million | NT$231.31 Million | NT$201.61 Million | ▲ +9.7% |
| 2017 | 0.80x | NT$478.86 Million | NT$601.08 Million | NT$367.66 Million | ▼ -85.4% |
| 2016 | 5.47x | NT$608.30 Million | NT$111.24 Million | NT$224.81 Million | ▲ +912.9% |
| 2015 | 0.54x | NT$347.66 Million | NT$643.97 Million | NT$229.54 Million | — |